ATE221200T1 - Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten - Google Patents

Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Info

Publication number: ATE221200T1
Authority: AT; Austria
Prior art keywords: autoantibodies; autoantigen; detection; patients; diabetes
Prior art date: 1993-04-16

Application number

AT94914094T

Other languages

English (en)

Inventor

Steinunn Baekkeskov

Henk-Jan Sophia Child Aanstoot

Original Assignee

Univ California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-16

Filing date

1994-04-08

Publication date

2002-08-15

1994-04-08 Application filed by Univ California filed Critical Univ California

2002-08-15 Application granted granted Critical

2002-08-15 Publication of ATE221200T1 publication Critical patent/ATE221200T1/de

Links

206010012601 diabetes mellitus Diseases 0.000 title 1
239000000725 suspension Substances 0.000 title 1
238000001514 detection method Methods 0.000 abstract 3
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
238000003556 assay Methods 0.000 abstract 2
210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 1
206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
102000008214 Glutamate decarboxylase Human genes 0.000 abstract 1
108091022930 Glutamate decarboxylase Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Rehabilitation Therapy (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Rheumatology (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT94914094T 1993-04-16 1994-04-08 Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten ATE221200T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4888693A	1993-04-16	1993-04-16
PCT/US1994/003896 WO1994024564A1 (en)	1993-04-16	1994-04-08	Methods for diabetes susceptibility assessment in asymptomatic patients

Publications (1)

Publication Number	Publication Date
ATE221200T1 true ATE221200T1 (de)	2002-08-15

Family

ID=21956973

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94914094T ATE221200T1 (de)	1993-04-16	1994-04-08	Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Country Status (6)

Country	Link
US (2)	US6316209B1 (de)
EP (1)	EP0693183B1 (de)
JP (1)	JP3425149B2 (de)
AT (1)	ATE221200T1 (de)
DE (1)	DE69431051T2 (de)
WO (1)	WO1994024564A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0693183B1 (de)	1993-04-16	2002-07-24	The Regents of the University of California	Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
EP0807253A1 (de) *	1995-01-31	1997-11-19	Novo Nordisk A/S	Verfahren zur diagnose der vorklinischen diabetes
US7189516B2 (en) *	2001-08-17	2007-03-13	Luminex Corporation	Method for characterizing autoimmune disorders
IN2014DN09410A (de)	2012-04-13	2015-07-17	Diabetomics Llc
GB201509575D0 (en) *	2015-06-03	2015-07-15	King S College London	Diagnostic target
MX2023001675A (es)	2018-01-10	2023-02-22	Brightseed Inc	Metodo para modular el metabolismo.
CA3148593A1 (en)	2019-07-29	2021-02-04	Brightseed, Inc.	Method for improving digestive health
AU2020383340A1 (en)	2019-11-11	2022-06-09	Brightseed, Inc	Extract, consumable product and method for enriching bioactive metabolite in an extract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
NL9001083A (nl)	1990-05-04	1991-12-02	Rijksuniversiteit	Beta-cel antigeen.
US5723286A (en) *	1990-06-20	1998-03-03	Affymax Technologies N.V.	Peptide library and screening systems
AU8721991A (en) *	1990-09-07	1992-03-30	Regents Of The University Of California, The	Methods for the diagnosis and treatment of diabetes
US5674692A (en) *	1991-09-06	1997-10-07	Baekkeskov; Steinunn	Methods for diabetes susceptibility assessment in asymptomatic patients
EP0693183B1 (de)	1993-04-16	2002-07-24	The Regents of the University of California	Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

1994
- 1994-04-08 EP EP94914094A patent/EP0693183B1/de not_active Expired - Lifetime
- 1994-04-08 WO PCT/US1994/003896 patent/WO1994024564A1/en not_active Ceased
- 1994-04-08 AT AT94914094T patent/ATE221200T1/de not_active IP Right Cessation
- 1994-04-08 JP JP52334094A patent/JP3425149B2/ja not_active Expired - Fee Related
- 1994-04-08 DE DE69431051T patent/DE69431051T2/de not_active Expired - Fee Related
1997
- 1997-09-25 US US08/937,955 patent/US6316209B1/en not_active Expired - Fee Related
2001
- 2001-11-13 US US09/993,371 patent/US6960448B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69431051D1 (de)	2002-08-29
EP0693183A4 (de)	1998-04-29
DE69431051T2 (de)	2003-03-13
US20050106633A1 (en)	2005-05-19
JP3425149B2 (ja)	2003-07-07
WO1994024564A1 (en)	1994-10-27
EP0693183A1 (de)	1996-01-24
US6316209B1 (en)	2001-11-13
JPH08509289A (ja)	1996-10-01
US6960448B2 (en)	2005-11-01
EP0693183B1 (de)	2002-07-24

Similar Documents

Publication	Publication Date	Title
Sowa et al.	1983	Athletic participation: Its relationship to student development.
EP1491889A3 (de)	2005-04-06	Verfahren zur Unterstützung der Diagnose der Alzheimerschen Krankheit durch Messung der Amyloid-Beta-Peptide(x =41) und Tau
DE602004011931D1 (de)	2008-04-03	Gleichenden diagnose von alzheimer
ATE269978T1 (de)	2004-07-15	Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit
DE68927459D1 (de)	1996-12-19	Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
SE9103332L (sv)	1993-05-14	Metod foer diagnos av blodkoagulationssjukdomar
DE69016951D1 (de)	1995-03-23	System zur Bestimmung der Tonerfüllhöhe.
BR0206364A (pt)	2005-08-16	Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
NO982265L (no)	1998-07-16	Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
DE69431051D1 (de)	2002-08-29	Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
ATE268908T1 (de)	2004-06-15	Verfahren zur diagnose und behandlung von diabetes
DE69204157D1 (de)	1995-09-21	Verfahren zur bestimmung von anti-rns-antikörpern.
CA2069611A1 (en)	1991-07-01	Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals
ATE275268T1 (de)	2004-09-15	Verfahren zur diagnose von sjögren-syndrom
EP0725277A3 (de)	1996-12-04	Variable Transskripte von T-Zellen als Marker für Krankheiten
ES2130629T3 (es)	1999-07-01	Compuestos peptidicos de proinsulina para detectar y tratar la diabetes tipo i.
Kasuga et al.	1997	Autoantibody against ICA512 did not improve test sensitivity for slowly progressive IDDM in adults
Petitti et al.	1982	Physiologic measures in men with and without vasectomies
EP1731913A3 (de)	2007-01-17	Verfahren und Zusammensetzungen zur Bestimmung des Lipidperoxidierungsgehaltes in oxidativen Stress-Syndromen und Krankheiten
MacKenzie et al.	1978	Evaluating the abbreviated injury scale
Yokokawa et al.	1989	Presence of anti-DNA antibody in diabetes mellitus: its relation to the duration of diabetes and diabetic complications
ATE211825T1 (de)	2002-01-15	Verfahren zur feststellung einer allergie
Sharp et al.	1996	Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone
Tull et al.	1997	Incidence of childhood-onset IDDM in black African-heritage populations in the Caribbean
ATE229650T1 (de)	2002-12-15	Verfahren zur diagnose von diabetes und praediabetischer bedingungen

Legal Events

Date	Code	Title	Description
2003-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties